S

Salvo Health

Subscription-based digital health for fatty liver

Overview

Salvo Health provides digital health services for metabolic liver diseases, mainly fatty liver disease. It runs a remote patient monitoring (RPM) platform that lets patients with conditions like MASLD and MASH stay connected with their care team via text, enabling real-time health management without frequent in-person visits. The service is delivered through a subscription model that includes personalized care plans and continuous access to clinicians, with potential reimbursements or partnership fees from payers and practices. How it differs from competitors is its focus on real-time, text-based communication and ongoing, personalized care for chronic liver and gut conditions via RPM, rather than one-off visits or generic digital programs. The company’s goal is to improve patient outcomes and satisfaction by making specialized liver-care more accessible, timely, and tailored to each patient’s needs.

Work here?Claim your company

About Salvo Health

Simplify's Rating
Why Salvo Health is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

51-200

Company Stage

Series A

Total Funding

$28M

Headquarters

New York City, New York

Founded

2021

Get referred to Salvo Health

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Salvo signed 801 gastroenterologists and 700-physician practices, showing strong distribution momentum in 2026.
  • Management reported 800% patient growth and eightfold revenue growth by April 2025, then $8.5M Series A.
  • The 2026 Lohman expansion into Ohio, Virginia, Maryland, Colorado, Massachusetts, and Washington broadens reach.

What critics are saying

  • Salvo depends on independent gastroenterology referrals; insurer reimbursement changes can crush unit economics quickly.
  • Clinical staffing expansion in 2026 creates execution risk; nurse and dietitian shortages delay deployments.
  • If GI practices internalize virtual care or competing platforms win contracts, Salvo loses distribution entirely.

What makes Salvo Health unique

  • Salvo Health embeds RPM inside local GI practices, not a standalone consumer clinic, as of 2026-10-27.
  • Its 2026 model bundles nurses, dietitians, and social workers with app-based care and billing.
  • Lohman partnership adds FDA-cleared home ECG monitoring across six states in 2026.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$28M

Above

Industry Average

Funded Over

4 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Below Average

Industry standards

$15M
$8.2M
$8.5M
$15M
$30M

Benefits

  • Health Insurance
  • Remote Work Options
  • Flexible Work Hours
  • Professional Development Budget

Growth & Insights and Company News

6 month growth

0%

1 year growth

-2%

2 year growth

-1%
Salvo Health
Oct 29th, 2026
Salvo Health Announces $8.5M Series A to Advance Hybrid Care Future for GI and Metabolic Treatment

Today, Salvo Health announced a $8.5M Series A funding round led by ManchesterStory, City Light Capital, and Threshold Ventures, with participation from new investors including The Artemis Fund, Contour Venture Partners, and others.

HIT Consultant
Feb 4th, 2026
Salvo Health raises $8.5M to support independent GI practices with AI-powered care platform

Salvo Health has raised $8.5 million in a Series A round led by ManchesterStory, City Light Capital and Threshold Ventures, following 800% revenue growth last year. The company provides wraparound support for independent gastroenterology practices rather than competing with them directly. The platform has signed 801 gastroenterologists, representing 16% of independent US practices. It offers patients access to registered dietitians, behavioural health specialists and nurses through AI-enabled continuous care that integrates with existing clinics. The hybrid model has delivered a 79% reduction in GI-related emergency room utilisation. Salvo addresses a fragmented market serving 100 million Americans with gastrointestinal issues, providing ongoing support for diet, stress management and medication adherence that independent practices typically cannot staff full-time.

FinSMEs
Jan 26th, 2026
Salvo Health Raises $8.5M in Series A Funding

Salvo Health raises $8.5M in Series A funding. Salvo Health, a New York-based provider of a virtual care platform specializing in gastrointestinal and metabolic health, raised $8.5m in Series A funding. The round was co-led by ManchesterStory, City Light Capital, and Threshold Ventures, with participation from new investors The Artemis Fund, Contour Venture Partners, Owl Capital, and Impact X Capital Partners, and existing investors Human Ventures, Torch Capital, Felicis Ventures, and Alumni Ventures. The company intends to use the funds to expand its engineering team for an AI-led roadmap and increase the national hiring of registered dietitians, behavioral health professionals, and nurses to meet rising patient demand. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, Salvo Health provides brick & mortar clinics with a continuous care platform that enables users to save time, increase revenue, and improve patient outcomes by offering direct access to a gut-focused care team. In 2025, the company has grown patients and revenue by 800% YoY and enterprise agreements with GI doctors by more than 1,000%. Salvo has also signed agreements with 801 GIs.

HIStalk Practice
Jun 9th, 2025
Home " News " Currently Reading:

Salvo Health announces $4 million in new funding.

MobiHealthNews
Jun 5th, 2025
Salvo Health raises $4M for expansion

Salvo Health raised $4M in an extended Seed Prime round, following a $5M investment last year. The funds will expand its clinical team and virtual care platform across GI partner clinics with 700 physicians. The company, which launched in 2022 with $10.5M funding, has seen an 800% rise in patient volume and aims to grow revenue sixfold by year-end. New investor The Artemis Fund joined existing investors in this round.

Recently Posted Jobs

Sign up to get curated job recommendations

Salvo Health is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs